Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Microenvironment‑driven resistance to B‑Raf inhibition in a melanoma patient is accompanied by broad changes of gene methylation and expression in distal fibroblasts.
Kodet O, Dvořánková B, Bendlová B, Sýkorová V, Krajsová I, Štork J, Kučera J, Szabo P, Strnad H, Kolář M, Vlček Č, Smetana K Jr, Lacina L. Kodet O, et al. Among authors: krajsova i. Int J Mol Med. 2018 May;41(5):2687-2703. doi: 10.3892/ijmm.2018.3448. Epub 2018 Feb 1. Int J Mol Med. 2018. PMID: 29393387 Free PMC article.
Cultivation-dependent plasticity of melanoma phenotype.
Kodet O, Dvořánková B, Krejčí E, Szabo P, Dvořák P, Štork J, Krajsová I, Dundr P, Smetana K Jr, Lacina L. Kodet O, et al. Among authors: krajsova i. Tumour Biol. 2013 Dec;34(6):3345-55. doi: 10.1007/s13277-013-0905-x. Epub 2013 Jun 12. Tumour Biol. 2013. PMID: 23757003
[Isolated Perfusion of the Upper Extremity with TNF-α - Double Venous Cannulation].
Špaček M, Mitáš P, Vočka M, Lacina L, Hodková G, Špunda R, Kodet O, Krajsová I, Petruželka L, Trnka J, Kubinyi J, Matějovský Z, Lambert L, Lindner J. Špaček M, et al. Among authors: krajsova i. Klin Onkol. 2017 Summer;30(3):213-219. doi: 10.14735/amko2017213. Klin Onkol. 2017. PMID: 28612619 Czech.
Serum proteomic analysis of melanoma patients with immunohistochemical profiling of primary melanomas and cultured cells: Pilot study.
Kučera J, Strnadová K, Dvořánková B, Lacina L, Krajsová I, Štork J, Kovářová H, Skalníková HK, Vodička P, Motlík J, Dundr P, Smetana K Jr, Kodet O. Kučera J, et al. Among authors: krajsova i. Oncol Rep. 2019 Nov;42(5):1793-1804. doi: 10.3892/or.2019.7319. Epub 2019 Sep 17. Oncol Rep. 2019. PMID: 31545456 Free PMC article.
The Abscopal Effect in the Era of Checkpoint Inhibitors.
Kodet O, Němejcova K, Strnadová K, Havlínová A, Dundr P, Krajsová I, Štork J, Smetana K Jr, Lacina L. Kodet O, et al. Among authors: krajsova i. Int J Mol Sci. 2021 Jul 4;22(13):7204. doi: 10.3390/ijms22137204. Int J Mol Sci. 2021. PMID: 34281259 Free PMC article. Review.
Improved survival with MEK inhibition in BRAF-mutated melanoma.
Flaherty KT, Robert C, Hersey P, Nathan P, Garbe C, Milhem M, Demidov LV, Hassel JC, Rutkowski P, Mohr P, Dummer R, Trefzer U, Larkin JM, Utikal J, Dreno B, Nyakas M, Middleton MR, Becker JC, Casey M, Sherman LJ, Wu FS, Ouellet D, Martin AM, Patel K, Schadendorf D; METRIC Study Group. Flaherty KT, et al. N Engl J Med. 2012 Jul 12;367(2):107-14. doi: 10.1056/NEJMoa1203421. Epub 2012 Jun 4. N Engl J Med. 2012. PMID: 22663011 Free article. Clinical Trial.
Vemurafenib in patients with BRAF(V600) mutated metastatic melanoma: an open-label, multicentre, safety study.
Larkin J, Del Vecchio M, Ascierto PA, Krajsova I, Schachter J, Neyns B, Espinosa E, Garbe C, Sileni VC, Gogas H, Miller WH Jr, Mandalà M, Hospers GA, Arance A, Queirolo P, Hauschild A, Brown MP, Mitchell L, Veronese L, Blank CU. Larkin J, et al. Among authors: krajsova i. Lancet Oncol. 2014 Apr;15(4):436-44. doi: 10.1016/S1470-2045(14)70051-8. Epub 2014 Feb 27. Lancet Oncol. 2014. PMID: 24582505 Clinical Trial.
37 results